What's in DR SURINDER SACHDEVA's pipeline?

DR SURINDER SACHDEVA has 3 drugs in our index: 3 marketed, 0 filed, 0 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with DR SURINDER SACHDEVA's portfolio?

No competitive overlap detected.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/dr-surinder-sachdeva.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-13 · How we verify

DR SURINDER SACHDEVA — Portfolio Competitive Intelligence Brief

DR SURINDER SACHDEVA pipeline: 3 marketed, 0 filed, 0 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

3 marketed 0 filed 0 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Area
TRISTRONTIUM ALUMINATE	TRISTRONTIUM ALUMINATE	marketed
THERACAL LC	THERACAL LC	marketed	Dental liner/base material	Dentistry
Mineral Tri-Oxide Aggregate	Mineral Tri-Oxide Aggregate	marketed		Dentistry/Endodontics

Therapeutic area mix

Dentistry · 1
Dentistry/Endodontics · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

No competitive overlap data.

Subscribe to ongoing alerts

Every new pipeline event for DR SURINDER SACHDEVA:

Cite this brief

Drug Landscape (2026). DR SURINDER SACHDEVA — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/dr-surinder-sachdeva. Accessed 2026-05-13.